147 related articles for article (PubMed ID: 22490664)
1. Chimeric hexon HVRs protein reflects partial function of adenovirus.
Yu B; Wang C; Dong J; Zhang M; Zhang H; Wu J; Wu Y; Kong W; Yu X
Biochem Biophys Res Commun; 2012 May; 421(2):170-6. PubMed ID: 22490664
[TBL] [Abstract][Full Text] [Related]
2. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
3. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH
Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866
[TBL] [Abstract][Full Text] [Related]
4. Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors.
Yan J; Dong J; Wu J; Zhu R; Wang Z; Wang B; Wang L; Wang Z; Zhang H; Wu H; Yu B; Kong W; Yu X
Sci Rep; 2016 Mar; 6():22464. PubMed ID: 26934960
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.
Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R
Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937
[TBL] [Abstract][Full Text] [Related]
6. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
8. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
[TBL] [Abstract][Full Text] [Related]
10. Identification of sites in adenovirus hexon for foreign peptide incorporation.
Wu H; Han T; Belousova N; Krasnykh V; Kashentseva E; Dmitriev I; Kataram M; Mahasreshti PJ; Curiel DT
J Virol; 2005 Mar; 79(6):3382-90. PubMed ID: 15731232
[TBL] [Abstract][Full Text] [Related]
11. [The modified restriction of amino acids of HVR1, HVR2, HVR5, HVR7 in human adenovirus serotype 3 hexon].
Zhou ZC; Liang HX; Li T; Zhong TH; Tian XG; Zhou R; Li X
Bing Du Xue Bao; 2012 Jun; 28(4):372-81. PubMed ID: 22978161
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.
Bradley RR; Maxfield LF; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(2):1267-72. PubMed ID: 22072746
[TBL] [Abstract][Full Text] [Related]
13. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.
Bruder JT; Chen P; Semenova E; Thomas CA; Konovalova S; Ekberg G; Ettyreddy D; McVey D; Gall JG; King CR; Brough DE
J Virol; 2013 Sep; 87(17):9661-71. PubMed ID: 23824800
[TBL] [Abstract][Full Text] [Related]
14. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
[TBL] [Abstract][Full Text] [Related]
15. Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches.
Gu L; Farrow AL; Krendelchtchikov A; Matthews QL
J Vis Exp; 2015 May; (99):e52655. PubMed ID: 25993057
[TBL] [Abstract][Full Text] [Related]
16. Stability of the seven hexon hypervariable region sequences of adenovirus types 1-6 isolated in Yamagata, Japan between 1988 and 2007.
Mizuta K; Matsuzaki Y; Hongo S; Ohmi A; Okamoto M; Nishimura H; Itagaki T; Katsushima N; Oshitani H; Suzuki A; Furuse Y; Noda M; Kimura H; Ahiko T
Virus Res; 2009 Mar; 140(1-2):32-9. PubMed ID: 19038295
[TBL] [Abstract][Full Text] [Related]
17. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
[TBL] [Abstract][Full Text] [Related]
18. [Sequencing of adenovirus type 7 vaccine strain fragment and characterization of the hexon encoding gene].
Jiang XL; Wang JW; Wen LY; Shi CX; Hong T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):305-9. PubMed ID: 15340538
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
[TBL] [Abstract][Full Text] [Related]
20. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.
Rux JJ; Burnett RM
Mol Ther; 2000 Jan; 1(1):18-30. PubMed ID: 10933908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
